Heath-Chiozzi Margo

CIK 00017181121 companyHAMPTON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001718112

Recent Transactions

30 trades

Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2025-06-05+82,000→ 82,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2024-06-13+82,000→ 82,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-06-03−6,289→ 0 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-03$33.65/sh−58,369→ 13,383 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-03$9.02/sh+6,289→ 13,383 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-03$10.38/sh+58,369→ 71,752 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-06-03−58,369→ 23,023 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$34.07/sh−38,719→ 7,094 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$2.78/sh+29,068→ 41,162 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$9.02/sh+2,043→ 43,205 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$10.38/sh+2,608→ 45,813 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−29,068→ 12,732 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−2,043→ 6,289 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−2,608→ 81,392 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2023-06-15+80,000→ 80,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2022-06-16+77,000→ 77,000 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-08$40.00/sh−600→ 11,247 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-12-08−600→ 41,800 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-08$2.78/sh+600→ 11,847 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-11-01−600→ 42,400 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$2.78/sh+600→ 11,847 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$41.71/sh−600→ 11,247 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-08-11$9.02/sh+10,000→ 11,247 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2021-08-11−10,000→ 8,332 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2021-06-17+62,500→ 62,500 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2020-06-18+84,000→ 84,000 total
Purchase
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2020-06-09$3.00/sh+1,000→ 1,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2019-06-19+43,000→ 43,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2018-06-13+275,000→ 275,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2017-10-03+75,000→ 75,000 total

Companies

Celldex Therapeutics, Inc.
SVP OF REGULATORY AFFAIRS
$CLDX

Recent Filings

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827

View on SEC.gov